SYMPLICITY™ BLOOD PRESSURE PROCEDURE

Clinical evidence and patient stories

The Symplicity blood pressure procedure is a complementary, minimally invasive procedure that is proven to be safe and effective in helping to lower blood pressure.1,2

  

Illustration of a doctor standing in front of a man and a woman

  

Clinical evidence

The Symplicity blood pressure procedure can help get your numbers moving in the right direction.1-2

Illustration of a circle outlined 65% with blue and the number 65% in the middle

65% experience a ≥ 5 mmHg reduction

Illustration of a circle outlined 50% with blue and the number 50% in the middle

50% experience a ≥ 10 mmHg reduction

Illustration of a circle outlined 35% with blue and the number 35% in the middle

35% experience a ≥ 15 mmHg reduction

* Studies focused on 388 people on and off medications.

Patient stories

More than 25,000 people worldwide have received this procedure.4 Listen to some of their stories to learn more.

Paul talks about how the Symplicity blood pressure procedure made a difference in his life.

These are individual experiences. Their thoughts and opinions are their own. Not everyone will experience the same results.

The Medtronic Symplicity blood pressure procedure does have known risks. These risks should be considered in relation to the potential benefits of the procedure.

Find a Symplicity specialist.

Here’s how you can find a doctor near you who is experienced in the Symplicity blood pressure procedure.

Is the Symplicity blood pressure procedure right for you?

Answer a few simple questions then talk to your doctor to see if the procedure may be right for you.

References

1

Kandzari DE, Townsend RR, Kario K, et al. Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications. J Am Coll Cardiol. November 7, 2023;82(19):1809–1823.

2

Böhm M, Kario K, Kandzari DE, et al. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. Lancet. May 2, 2020;395(10234):1444–1451.

3

Symplicity Spyral™ Renal Denervation System. FDA Presentation. US FDA Circulatory Systems Devices Panel. Meeting date August 23, 2023.

4

Medtronic data on file. RDN Catheter Historical Data, June 2023. Data include both Symplicity Flex and Symplicity Spyral.

CONTACT

Sign up for updates about the Symplicity blood pressure procedure.

Sign up